Inquis Medical, Inc. is a privately clinical stage medical device company based in Silicon Valley. Our company legacy is built on decades of developing, launching, and supporting novel, physician-tested medical devices that address unmet needs, with a long-lasting impact. Inquis Medical’s team is focused on improving the management of venous thromboembolic diseases. Our innovative team has developed a proprietary next-generation thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss. For inquiries contact info@inquismedical.com.
Location: United States
Employees: 11-50
Total raised: $115M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 04.11.2023 | Yu Galaxy | yugalaxy.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.01.2026 | Series C | $75M | - |
| 08.11.2024 | Series B | $40M | - |
Mentions in press and media 8
| Date | Title | Description |
| 14.01.2026 | Inquis Medical Accelerates VTE Treatment with $75M Series C Funding for AVENTUS System | Inquis Medical secured $75 million in Series C funding. An undisclosed strategic investor provided the substantial capital. This investment dramatically accelerates the nationwide commercial rollout of the innovative AVENTUS thrombectomy sy... |
| 13.01.2026 | Inquis Medical Raises $75M in Series C Funding | Inquis Medical, a Menlo Park, California-based developer of a thrombectomy system, raised $75m in Series C funding. The investment was provided by an undisclosed strategic investor. The company intends to use the funds to accelerate nationw... |
| 12.01.2026 | Inquis Medical: $75 Million Series C Raised To Expand AVENTUS Thrombectomy Commercial Rollout | Inquis Medical announced it closed a $75 million Series C financing to accelerate nationwide commercial expansion of its AVENTUS thrombectomy system and advance a next-generation product pipeline, as the company looks to scale adoption in v... |
| 08.11.2024 | Inquis Medical: Thrombectomy Systems Focused Company Raises $40 Million (Series B) | Inquis Medical, a medical technology company specializing in advanced thrombectomy systems, announced the closing of its $40 million Series B funding round. This funding round was led by Marshall Wace (a globally recognized investment firm)... |
| 05.11.2024 | Inquis Medical Secures $40 Million to Revolutionize Thrombectomy Technology | Inquis Medical, a Menlo Park-based innovator in medical technology, has just landed a significant $40 million in Series B financing. This funding round, led by Marshall Wace, signals a strong vote of confidence in the company’s mission to e... |
| 05.11.2024 | Inquis Medical Raises $40M in Series B Financing | Inquis Medical, a Menlo Park, CA-based medical technology company specializing in advanced thrombectomy systems, raised $40M in Series B funding. The round was led by Marshall Wace, with participation from existing investors, including Shan... |
| 04.11.2024 | Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases | Financing led by Marshall Wace MENLO PARK, Calif.–(BUSINESS WIRE)–November 4, 2024– Inquis Medical, a pioneering medical technology company specializing in advanced thrombectomy systems, today announced the successful closure of its $40 mil... |
| - | Inquis Medical | “Inquis Medical is a privately funded medical device company dedicated to advancing the treatment of venous thromboembolic diseases.” |